Skip to main content

Beacon Pointe Advisors, LLC

SEC CIK
0001744317
Latest filing
Aug 18, 2026

AVXL holding history

Anavex Life Sciences Corp. in every 13F filed by Beacon Pointe Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVXL overviewAll 13F holders of AVXLFull Q2 2026 holdings

Shares (Q2 2026)
23,185
Value
$60.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AVXL by Beacon Pointe Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202623,185$60.0K<0.1%+185+0.8%AddedHolders
Q1 202623,000$70.6K<0.1%00.0%UnchangedHolders
Q4 202523,000$81.9K<0.1%00.0%UnchangedHolders
Q3 202523,000$204.7K<0.1%00.0%UnchangedHolders
Q2 202523,000$212.1K<0.1%00.0%UnchangedHolders
Q1 202523,000$197.3K<0.1%00.0%UnchangedHolders
Q4 202423,000$247.0K<0.1%00.0%UnchangedHolders
Q3 202423,000$130.6K<0.1%00.0%UnchangedHolders
Q2 202423,000$97.1K<0.1%+5,000+27.8%AddedHolders
Q1 202418,000$91.6K<0.1%00.0%UnchangedHolders
Q4 202318,000$167.6K<0.1%−225−1.2%ReducedHolders
Q3 202318,225$119.4K<0.1%+225+1.3%AddedHolders
Q2 202318,000$146.3K<0.1%00.0%UnchangedHolders
Q1 202318,000$154.3K<0.1%00.0%UnchangedHolders
Q4 202218,000$166.7K<0.1%00.0%UnchangedHolders
Q3 202218,000$186.0K<0.1%00.0%UnchangedHolders
Q2 202218,000$180.0K<0.1%00.0%UnchangedHolders
Q1 202218,000$222.0K<0.1%−225−1.2%ReducedHolders
Q4 202118,225$316.0K<0.1%00.0%UnchangedHolders
Q3 202118,225$327.0K<0.1%00.0%UnchangedHolders
Q2 202118,225$417.0K<0.1%00.0%UnchangedHolders
Q1 202118,225$272.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.